Maturity-onset diabetes of the young type 9 or latent autoimmune diabetes in adults: A case report and review of literature

被引:0
作者
Guang-Hong Zhou [1 ]
Min Tao [1 ]
Qing Wang [1 ]
Xing-Yu Chen [1 ]
Jing Liu [1 ]
Li-Li Zhang [1 ]
机构
[1] Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Maturity-onset diabetes of the young(MODY) is a monogenic genetic disease often clinically misdiagnosed as type 1 or type 2 diabetes. MODY type 9(MODY9) is a rare subtype caused by mutations in the PAX4 gene. Currently, there are limited reports on PAX4-MODY, and its clinical characteristics and treatments are still unclear. In this report, we described a Chinese patient with high autoimmune antibodies, hyperglycemia and a site mutation in the PAX4 gene.CASE SUMMARY A 42-year-old obese woman suffered diabetes ketoacidosis after consuming substantial amounts of beverages. She had never had diabetes before, and no one in her family had it. However, her autoantibody tested positive, and she managed her blood glucose within the normal range for 6 mo through lifestyle interventions. Later, her blood glucose gradually increased. Next-generation sequencing and Sanger sequencing were performed on her family. The results revealed that she and her mother had a heterozygous mutation in the PAX4 gene(c.314G>A, p.R105H), but her daughter did not. The patient is currently taking liraglutide(1.8 mg/d), and her blood glucose levels are under control. Previous cases were retrieved from PubMed to investigate the relationship between PAX4 gene mutations and diabetes.CONCLUSION We reported the first case of a PAX4 gene heterozygous mutation site(c.314G>A, p.R105H), which does not appear pathogenic to MODY9 but may facilitate the progression of latent autoimmune diabetes in adults.
引用
收藏
页码:1137 / 1145
页数:9
相关论文
共 22 条
[1]   Pax4 Gene Delivery Improves Islet Transplantation Efficacy by Promoting β Cell Survival and α-to-β Cell Transdifferentiation [J].
Parajuli, Keshab R. ;
Zhang, Yanqing ;
Cao, Alexander M. ;
Wang, Hongjun ;
Fonseca, Vivian A. ;
Wu, Hongju .
CELL TRANSPLANTATION, 2020, 29
[2]  
Ghanim Husam,Batra Manav,Green Kelly,Abuaysheh Sanaa,Hejna Jeanne,Makdissi Antione,Borowski Robert,Kuhadiya Nitesh D,Chaudhuri Ajay,Dandona Paresh.Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss[J].Diabetes, obesity & metabolism,2020
[3]  
Dejgaard Thomas F,Schmidt Signe,Frandsen Christian S,Vistisen Dorte,Madsbad Sten,Andersen Henrik U,Nørgaard Kirsten.Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial[J].Diabetes, obesity & metabolism,2020
[4]   Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes [J].
Kuhadiya, Nitesh D. ;
Prohaska, Ben ;
Ghanim, Husam ;
Dandona, Paresh .
DIABETES OBESITY & METABOLISM, 2019, 21 (04) :1054-1057
[5]  
Jana Urbanova,Ludmila Brunerova,Jan Broz.Hypoglycemia and antihyperglycemic treatment in adult MODY patients – A systematic review of literature[J].Diabetes Research and Clinical Practice,2019
[6]  
Lee Gung,Jang Hagoon,Kim Ye Young,Choe Sung Sik,Kong Jinuk,Hwang Injae,Park Jeu,Im Seung-Soon,Kim Jae Bum.SREBP1c-PAX4 Axis Mediates Pancreatic β Cell Compensatory Responses Upon Metabolic Stress[J].Diabetes,2018
[7]  
Kanako Tamura,Kohtaro Minami,Maya Kudo,Keisuke Iemoto,Harumi Takahashi,Susumu Seino.Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice[J].PLoS ONE,2017
[8]  
Açiksari Ayşegül,Duruksu Gökhan,Karaöz Erdal.Improved insulin-secreting properties of pancreatic islet mesenchymal stem cells by constitutive expression of Pax4 and MafA[J].Turkish journal of biology = Turk biyoloji dergisi,2017
[9]  
Petruzelkova L,Dusatkova P,Cinek O,Sumnik Z,Pruhova S,Hradsky O,Vcelakova J,Lebl J,Kolouskova S.Substantial proportion of MODY among multiplex families participating in a Type 1 diabetes prediction programme[J].Diabetic medicine : a journal of the British Diabetic Association,2016
[10]   Protective Action of Liraglutide in Beta Cells Under Lipotoxic Stress Via PI3K/Akt/FoxO1 Pathway [J].
Shao, Shiying ;
Nie, Mingbo ;
Chen, Cai ;
Chen, Xi ;
Zhang, Muxun ;
Yuan, Gang ;
Yu, Xuefeng ;
Yang, Yan .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2014, 115 (06) :1166-1175